Please login to the form below

Not currently logged in


This page shows the latest lampalizumab news and features for those working in and with pharma, biotech and healthcare.

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway

Lampalizumab in phase III for age-related maculardegeneration.  . Roche has started enrolling patients into phase III trials of lampalizumab for dry age-related macular degeneration (AMD) - a major cause of blindness. ... With the phase III trials for

Latest news

  • Roche moves eye drug lampalizumab into phase III Roche moves eye drug lampalizumab into phase III

    Sandra Horning, head of global product development and chief medical officer at Roche, said: “Lampalizumab has the potential to represent a significant breakthrough for this disease and could provide real hope ... To date lampalizumab showed a 20%

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....